Free Trial

Aditxt (ADTX) Competitors

Aditxt logo
$1.16 -0.08 (-6.10%)
As of 03:46 PM Eastern

ADTX vs. SNSE, CSCI, PHXM, NLSP, BCDA, GLYC, ADXN, LSB, TLPH, and APRE

Should you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Sensei Biotherapeutics (SNSE), COSCIENS Biopharma (CSCI), PHAXIAM Therapeutics (PHXM), NLS Pharmaceutics (NLSP), BioCardia (BCDA), GlycoMimetics (GLYC), Addex Therapeutics (ADXN), LakeShore Biopharma (LSB), Talphera (TLPH), and Aprea Therapeutics (APRE). These companies are all part of the "pharmaceutical products" industry.

Aditxt vs. Its Competitors

Sensei Biotherapeutics (NASDAQ:SNSE) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Sensei Biotherapeutics has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.

Sensei Biotherapeutics has a net margin of 0.00% compared to Aditxt's net margin of -46,082.47%. Sensei Biotherapeutics' return on equity of -66.72% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
Sensei BiotherapeuticsN/A -66.72% -57.10%
Aditxt -46,082.47%-389.10%-84.71%

Sensei Biotherapeutics currently has a consensus price target of $90.00, suggesting a potential upside of 922.73%. Given Sensei Biotherapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe Sensei Biotherapeutics is more favorable than Aditxt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensei Biotherapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Aditxt
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

10.5% of Sensei Biotherapeutics shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 23.2% of Sensei Biotherapeutics shares are owned by insiders. Comparatively, 0.0% of Aditxt shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Aditxt had 3 more articles in the media than Sensei Biotherapeutics. MarketBeat recorded 3 mentions for Aditxt and 0 mentions for Sensei Biotherapeutics. Aditxt's average media sentiment score of 0.86 beat Sensei Biotherapeutics' score of 0.00 indicating that Aditxt is being referred to more favorably in the news media.

Company Overall Sentiment
Sensei Biotherapeutics Neutral
Aditxt Positive

Sensei Biotherapeutics has higher earnings, but lower revenue than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensei BiotherapeuticsN/AN/A-$30.16M-$23.00-0.38
Aditxt$130K18.84-$34.45MN/AN/A

Summary

Sensei Biotherapeutics beats Aditxt on 9 of the 14 factors compared between the two stocks.

Get Aditxt News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADTX vs. The Competition

MetricAditxtMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.45M$2.37B$5.44B$8.92B
Dividend YieldN/A1.78%5.22%4.00%
P/E RatioN/A8.8927.2520.05
Price / Sales18.84666.36426.50117.27
Price / CashN/A21.7726.2128.59
Price / Book-0.764.507.925.57
Net Income-$34.45M$31.26M$3.17B$248.56M
7 Day Performance-9.77%5.60%4.48%7.44%
1 Month Performance-25.00%5.93%2.80%8.43%
1 Year Performance-99.99%8.83%35.04%21.72%

Aditxt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADTX
Aditxt
N/A$1.16
-6.1%
N/A-100.0%$2.45M$130K0.0060High Trading Volume
SNSE
Sensei Biotherapeutics
4.1746 of 5 stars
$8.58
-1.2%
$90.00
+949.0%
-27.1%$10.81MN/A-0.3740
CSCI
COSCIENS Biopharma
N/A$3.40
+1.8%
N/AN/A$10.71M$9.59M-0.5920Gap Down
PHXM
PHAXIAM Therapeutics
N/A$3.10
flat
N/AN/A$10.58M$32.66M0.0049
NLSP
NLS Pharmaceutics
N/A$2.90
+3.9%
N/A+1,191.0%$10.44MN/A0.006News Coverage
Analyst Upgrade
BCDA
BioCardia
3.9753 of 5 stars
$1.95
-9.3%
$25.00
+1,182.1%
-29.0%$10.10M$60K-0.8440Positive News
GLYC
GlycoMimetics
1.1504 of 5 stars
$0.16
-6.6%
N/A-99.4%$10.00M$10K-0.3450High Trading Volume
ADXN
Addex Therapeutics
2.5406 of 5 stars
$9.41
+4.6%
$30.00
+218.8%
+7.0%$9.98M$460K-27.6830
LSB
LakeShore Biopharma
0.3421 of 5 stars
$1.02
+11.0%
N/AN/A$9.50M$80.82M0.00773Positive News
Gap Up
High Trading Volume
TLPH
Talphera
1.9603 of 5 stars
$0.46
-1.7%
$5.00
+986.5%
-50.5%$9.43M$650K-1.0219Gap Up
APRE
Aprea Therapeutics
2.5085 of 5 stars
$1.69
+0.9%
$15.50
+817.2%
-54.9%$9.35M$1.50M-0.717

Related Companies and Tools


This page (NASDAQ:ADTX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners